Hims & Hers Health, Inc.(HIMS)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
HIMS | 6.26 B | -43.47x | 38.20% | -5.51% | $-0.64 | -32.03% | 4.77 | - | $65.30 | $13.74 |
LH | 26.88 B | 27.40x | 5.80% | 6.99% | $12.10 | 11.73% | 0.79 | 86.00% | $341.07 | $242.07 |
GH | 21.61 B | -46.01x | 44.30% | -38.33% | $-3.50 | - | - | - | $176.58 | $53.40 |
BTSG | 12.15 B | 54.85x | 23.00% | 2.55% | $1.12 | 13.04% | 1.16 | - | $73.75 | $22.86 |
DVA | 11.59 B | 15.81x | 5.20% | 6.05% | $11.49 | 88.48% | 12.42 | - | $247.49 | $101.00 |
Peer Valuation & Performance Analysis
Peer group analysis for Hims & Hers Health, Inc. (HIMS) compared to its primary competitors (including LH, GH, BTSG) reveals distinct metrics. HIMS trades at a valuation discount relative to its competitors, with a P/E ratio of -43.5x versus the peer average of 13.0x (representing a 434% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, HIMS's revenue growth of 38.2% exceeds the peer average of 19.6%, highlighting its competitive strength and market share gains. Additionally, its net margin of -5.5% is comparable to the peer average of -5.7%.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• HIMS ranks #0 in P/E ratio, #2 in revenue growth, and #4 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-09-03 | $28.88 | $29.12 | $27.55 | $27.82 | 12,151,300 | -3.67% |
| 2026-09-02 | $28.33 | $29.38 | $28.15 | $28.68 | 7,896,300 | +1.24% |
| 2026-09-01 | $29.28 | $29.87 | $28.38 | $28.44 | 7,304,700 | -2.87% |
| 2026-08-31 | $28.67 | $29.79 | $28.63 | $29.58 | 8,308,000 | +3.17% |
| 2026-08-28 | $31.36 | $31.40 | $28.52 | $28.84 | 14,726,300 | -8.04% |
| 2026-08-27 | $30.40 | $31.98 | $29.72 | $31.66 | 9,616,400 | +4.14% |
| 2026-08-26 | $31.04 | $31.63 | $29.62 | $29.83 | 11,584,200 | -3.90% |
| 2026-08-25 | $31.29 | $32.51 | $30.73 | $31.75 | 9,636,300 | +1.47% |
| 2026-08-24 | $32.44 | $32.72 | $30.30 | $31.08 | 13,872,600 | -4.19% |
| 2026-08-21 | $31.67 | $34.46 | $31.60 | $33.78 | 14,706,500 | +6.66% |
| 2026-08-20 | $30.66 | $33.16 | $30.66 | $31.86 | 18,885,300 | +3.91% |
| 2026-08-19 | $27.55 | $31.27 | $27.41 | $31.09 | 19,950,500 | +12.85% |
| 2026-08-18 | $27.85 | $28.85 | $27.38 | $27.39 | 7,898,400 | -1.65% |
| 2026-08-17 | $28.14 | $28.73 | $27.51 | $28.61 | 10,349,600 | +1.67% |
| 2026-08-14 | $29.15 | $29.30 | $28.11 | $28.15 | 8,973,800 | -3.43% |
Explore More Analysis for HIMS
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.